Aarti Surfactants Ltd's Q3FY25 Quarter Results
- 2d ago
Result Summary
- Aarti Surfactants Ltd reported a 6.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 17.2%.
- Its expenses for the quarter were up by 4.8% QoQ and 24.5% YoY.
- The net profit decreased 55.8% QoQ and decreased 88.0% YoY.
- The earnings per share (EPS) of Aarti Surfactants Ltd stood at 0.9 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 162.62 | 152.85 | 138.78 | 6.4% | 17.2% |
Total Expenses | 161.41 | 154.03 | 129.69 | 4.8% | 24.5% |
Profit Before Tax | 1.21 | 3.01 | 9.09 | -59.8% | -86.7% |
Tax | 0.41 | 1.21 | 2.40 | -66.1% | -82.9% |
Profit After Tax | 0.80 | 1.81 | 6.68 | -55.8% | -88.0% |
Earnings Per Share | 0.90 | 2.10 | 7.90 | -57.1% | -88.6% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Aarti Surfactants Ltd is a company primarily engaged in the manufacturing of surfactants, which are essential components in the production of cleaning agents, detergents, and personal care products. The company operates within the chemical industry, providing raw materials that are integral to various sectors, including household, industrial, and institutional cleaning, as well as personal care and other specialty applications. As of the latest available data, no specific recent major developments have been stated. This overview is based on general industry knowledge and may not reflect the most current information specific to Aarti Surfactants Ltd.
Revenue
In the third quarter of fiscal year 2025 (Q3FY25), Aarti Surfactants Ltd reported a total income of ₹162.62 crores. This represents a sequential increase of 6.4% from the previous quarter (Q2FY25), where the total income was ₹152.85 crores. Year-over-year, the total income grew by 17.2% compared to ₹138.78 crores recorded in Q3FY24. These figures indicate a strong growth trajectory in revenue for the company over both the quarterly and annual periods. The revenue growth can be attributed to various factors, which could include increased sales volume, price adjustments, or expansion into new markets or product lines, although specific drivers are not detailed in the provided data.
Profitability
The financial performance of Aarti Surfactants Ltd in terms of profitability has seen some fluctuations. For Q3FY25, the company reported a profit before tax (PBT) of ₹1.21 crores, which is significantly lower than ₹3.01 crores in Q2FY25, representing a quarter-over-quarter decline of 59.8%. Compared to Q3FY24, where the PBT was ₹9.09 crores, there is an 86.7% decrease year-over-year. Consequently, the profit after tax (PAT) for Q3FY25 was ₹0.80 crores, down from ₹1.81 crores in the previous quarter and ₹6.68 crores in the same quarter last year, reflecting declines of 55.8% and 88.0%, respectively. This downward trend in profitability metrics suggests a challenging quarter for the company, with notable declines in earnings as reflected in the earnings per share (EPS), which decreased from ₹2.10 in Q2FY25 to ₹0.90 in Q3FY25, and from ₹7.90 in Q3FY24, marking a YoY decline of 88.6%.
Operating Metrics
Analyzing the operating metrics for Aarti Surfactants Ltd, total expenses for Q3FY25 were recorded at ₹161.41 crores. This marks an increase of 4.8% from the previous quarter's expenses of ₹154.03 crores and a 24.5% rise from ₹129.69 crores in Q3FY24. The growth in expenses outpaced the growth in total income for both the quarterly and annual comparisons, which has implications for the company's cost management and operational efficiency. The increase in expenses could be attributed to higher input costs, operational expansions, or other administrative and operational factors. However, the specific drivers of expense changes are not detailed in the data provided. These operating results provide insights into the company's financial health and operational challenges in managing costs relative to revenue growth.
